710 Keynote-B59: dose escalation of a phase 1/2 first-in-human, open-label study of GI-101, a novel immunocytokine combining CD80-IL2v, in combination with pembrolizumab in advanced solid tumors

• John Powderly,
• Jae Lyun Lee,
• Jung-Yun Lee,
• Byoung Chul Cho,
• Kyoung-Ho Pyo,
• Soohyeon Lee,
• Dong Kim,
• Myoung Ho Jang,
• Byoung Yong Shim,
• Sang Joon Shin,
• Nari Yun,
• Mina Ham,
• Julia Cohen,
• Hyo Jin Lee,
• Kyoyoung Lee,
• Hyunjin Kang,
• Jea Hwan Kim,
• Mi hyun Kim

Affiliations

John Powderly

6Carolina BioOncology Institute, Huntersville, NC, USA

Jae Lyun Lee

2Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Jung-Yun Lee

5Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea

Byoung Chul Cho

1Yonsei Cancer Center and Severance Hospital, Seoul, Republic of Korea

Kyoung-Ho Pyo

10Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

Soohyeon Lee

7Korea University Anam Hospital, Seoul, Republic of Korea

Dong Kim

11Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea

Myoung Ho Jang

9GI Innovation, Inc, Seoul, Republic of Korea

Byoung Yong Shim

3St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea

Sang Joon Shin

1Yonsei Cancer Center and Severance Hospital, Seoul, Republic of Korea

Nari Yun

9GI Innovation, Inc, Seoul, Republic of Korea

Mina Ham

9GI Innovation, Inc, Seoul, Republic of Korea

Julia Cohen

8Merck and Co., Inc., Rahway, NJ, USA

Hyo Jin Lee

4Chungnam National University Hospital, Daejeon, Republic of Korea

Kyoyoung Lee

9GI Innovation, Inc, Seoul, Republic of Korea

Hyunjin Kang

9GI Innovation, Inc, Seoul, Republic of Korea

Jea Hwan Kim

10Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

Mi hyun Kim

10Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea